CN114874301A - Preparation method and application of β-conglycinin composed of different subunits - Google Patents
Preparation method and application of β-conglycinin composed of different subunits Download PDFInfo
- Publication number
- CN114874301A CN114874301A CN202210507021.7A CN202210507021A CN114874301A CN 114874301 A CN114874301 A CN 114874301A CN 202210507021 A CN202210507021 A CN 202210507021A CN 114874301 A CN114874301 A CN 114874301A
- Authority
- CN
- China
- Prior art keywords
- conglycinin
- preparation
- water
- protein
- supernatant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种不同亚基组成β‑伴大豆球蛋白的制备方法,过程包括:在45℃、pH为8.5下对脱脂大豆粉进行提取,并以CaCl2沉淀剂对β‑伴大豆球蛋白进行沉淀,将制备得到的不同亚基组成β‑伴大豆球蛋白在制备降血脂药物中的应用。
The invention discloses a preparation method of β-conglycinin composed of different subunits. The process includes: extracting defatted soybean flour at 45° C. and pH of 8.5, and using CaCl 2 precipitation agent to prepare β-conglycinin. The application of β-conglycinin in the preparation of hypolipidemic drugs by precipitation of protein, and the preparation of different subunits to form β-conglycinin.
Description
技术领域technical field
本发明涉及不同亚基组成β-伴大豆球蛋白的制备技术领域,更具体地说是涉及不同亚基组成β-伴大豆球蛋白的制备方法及应用。The invention relates to the technical field of preparation of β-conglycinin composed of different subunits, and more particularly to a preparation method and application of β-conglycinin composed of different subunits.
背景技术Background technique
生活水平的提高使得消费者对动物蛋白质的需求逐年增加,但由于存在高脂肪、高热量和高胆固醇的缺点,会导致高脂血症和并发症的增加。现在主要以他汀类药作为降脂药物,但在治疗过程中会产生一定程度的副作用。因此,在绿色理念和健康的时代,鼓励人们寻找新的植物蛋白来源。大豆作为营养最丰富的豆类,其蛋白质、脂肪和碳水化合物含量分别约为40%、18%和25%,被誉为“豆中之王”。大豆蛋白具有丰富的氨基酸(包括人体所需的8种氨基酸),其价值接近世界卫生组织和联合国粮农组织制定的必需氨基酸要求。The improvement of living standards makes consumers' demand for animal protein increase year by year, but due to the disadvantages of high fat, high calorie and high cholesterol, it will lead to an increase in hyperlipidemia and complications. At present, statins are mainly used as lipid-lowering drugs, but there will be a certain degree of side effects during the treatment. Therefore, in the age of green ideas and health, people are encouraged to look for new sources of plant protein. Soybeans are the most nutritious beans, with protein, fat and carbohydrate content of about 40%, 18% and 25%, respectively, and are known as "the king of beans". Soy protein is rich in amino acids (including 8 amino acids required by the human body), and its value is close to the essential amino acid requirements established by the World Health Organization and the United Nations Food and Agriculture Organization.
人们已经意识到单独饮食或与药物一起治疗对高脂血症和高胆固醇血症的重要性,饮食疗法也朝着这个方向发展。每天摄入2.75%的β-伴大豆球蛋白降低高胆固醇饮食喂养大鼠的血浆TC和TG。Ferreira等发现β-伴大豆球蛋白与非诺贝特和瑞舒伐他汀在控制血浆TG,HDL-C和TC方面具有相同的效果,表明该蛋白与瑞舒伐他汀的结合改变了药物在体内稳态中的作用。Liu等比较高胆固醇血症小鼠中β-伴大豆球蛋白与SPI血浆TC降低的活性大小。发现β-伴大豆球蛋白通过抑制胆固醇吸收和增加胆汁酸合成来降低血浆胆固醇。总之,研发大豆蛋白产品对多种疾病具有有益作用,特别是对于那些药理学方法无效或有不良副作用的患者。The importance of diet alone or in combination with medication for hyperlipidemia and hypercholesterolemia has been recognized, and dietary therapy has also been developed in this direction. Daily intake of 2.75% β-conglycinin reduces plasma TC and TG in high cholesterol diet-fed rats. Ferreira et al found that β-conglycinin had the same effect as fenofibrate and rosuvastatin in controlling plasma TG, HDL-C and TC, indicating that the binding of this protein to rosuvastatin altered the drug in vivo role in homeostasis. Liu et al compared the magnitude of the activity of β-conglycinin and SPI plasma TC reduction in hypercholesterolemic mice. β-Conglycinin was found to lower plasma cholesterol by inhibiting cholesterol absorption and increasing bile acid synthesis. In conclusion, the development of soy protein products has beneficial effects on a variety of diseases, especially for those patients for whom pharmacological approaches are ineffective or have adverse side effects.
Lovati等首次证实了体内β-伴大豆球蛋白具有保健功效的作用。在这项研究中,摄入β-伴大豆球蛋白的大鼠比对照组的血浆胆固醇(TC)浓度降低了35%,此结果与瑞舒伐他汀的效果一样;进一步发现,β-伴大豆球蛋白显著降低大鼠的甘油三酯(TG)水平;随后发现,α+α′亚基具有更高的LDL受体,上调活性高于β亚基。此外,Manzoni等通过跟踪标记人肝癌HepG2细胞中的LDL摄取和降解,评估β-伴大豆球蛋白纯化的α′亚基调节LDL受体活性的能力,结果发现α′亚基对LDL受体的上调显著大于对照细胞的LDL受体。同时,荧光标记的β-伴大豆球蛋白在HepG2细胞中的亚细胞定位进一步证实了先前的间接证据,即α′亚基在细胞胆固醇稳态中起关键作用,揭示了β-伴大豆球蛋白与硫氧还蛋白-1(Trx1)和血清亲环素B(CypB)的潜在关系。Fukui研究发现在排除异黄酮的影响下,口服α′亚基可显著降低大鼠血浆TC和TG水平,证实了β-伴大豆球蛋白和α′亚基在细胞系统中的作用以及β-伴大豆球蛋白在血脂异常调节的作用。但鲜有报道控制蛋白亚基来研究蛋白的降血脂功能。Lovati et al. for the first time confirmed the role of β-conglycinin in health care in vivo. In this study, rats ingested β-conglycinin had a 35% lower plasma cholesterol (TC) concentration than the control group, a result that was as effective as rosuvastatin; it was further found that β-conglycinin Globulin significantly reduced triglyceride (TG) levels in rats; it was subsequently found that the α+α' subunit had a higher LDL receptor with higher up-regulation activity than the β subunit. In addition, Manzoni et al. assessed the ability of β-conglycinin-purified α' subunits to modulate LDL receptor activity by tracking the uptake and degradation of LDL in labeled human hepatoma HepG2 cells, and found that the α' subunit's effect on LDL receptors The upregulation of LDL receptors was significantly greater than that of control cells. Meanwhile, the subcellular localization of fluorescently labeled β-conglycinin in HepG2 cells further confirmed previous indirect evidence that the α′ subunit plays a key role in cellular cholesterol homeostasis, revealing that β-conglycinin Potential relationship to thioredoxin-1 (Trx1) and serum cyclophilin B (CypB). Fukui's study found that oral administration of α' subunits could significantly reduce plasma TC and TG levels in rats under the exclusion of isoflavones, confirming the role of β-conglycinin and α' subunits in cellular systems and The role of glycinin in dyslipidemia regulation. However, there are few reports on the control of protein subunits to study the hypolipidemic function of proteins.
自20世纪50年代起,人们一直不断地研究β-伴大豆球蛋白与大豆球蛋白的分离方法,主要包括盐析法和碱溶酸沉法。碱溶酸沉法因其较好的得率和纯度被视为经典的分离方法,Saio法分离的β-伴大豆球蛋白和大豆球蛋白部分没有完全分离,且纯度较低。而Thanh法会将β-伴大豆球蛋白类似物转换成游离状态造成交叉污染,使所得组分的含量较低。Nagano方法具有分离效果好和纯度高等优点,但缺点是提取率较低。Since the 1950s, people have been continuously researching the separation methods of β-conglycinin and glycinin, mainly including salting out method and alkali-soluble acid precipitation method. Alkali-soluble acid precipitation method is regarded as a classic separation method because of its better yield and purity. The β-conglycinin and glycinin fractions separated by Saio method are not completely separated, and the purity is low. However, the Thanh method will convert the β-conglycinin analog into free state, resulting in cross-contamination, resulting in a lower content of the resulting component. The Nagano method has the advantages of good separation effect and high purity, but the disadvantage is that the extraction rate is low.
因此,如何提供一种提取率高的不同亚基组成β-伴大豆球蛋白是本领域技术人员亟需解决的问题。Therefore, how to provide β-conglycinin composed of different subunits with high extraction rate is an urgent problem to be solved by those skilled in the art.
发明内容SUMMARY OF THE INVENTION
有鉴于此,本发明提供了一种不同亚基组成β-伴大豆球蛋白的制备方法。In view of this, the present invention provides a preparation method of β-conglycinin with different subunit compositions.
为了实现上述目的,本发明采用如下技术方案:In order to achieve the above object, the present invention adopts the following technical solutions:
一种不同亚基组成β-伴大豆球蛋白的制备方法,包括下述步骤:A preparation method of β-conglycinin composed of different subunits, comprising the steps of:
在45℃、pH为8.5下对脱脂大豆粉进行提取,并以CaCl2沉淀剂对β-伴大豆球蛋白进行沉淀。Defatted soybean meal was extracted at 45°C, pH 8.5, and β-conglycinin was precipitated with a CaCl2 precipitant.
作为上述技术方案优选的技术方案,在45℃、pH为8.5下对脱脂大豆粉进行提取的过程包括:As a preferred technical solution of the above technical solution, the process of extracting defatted soybean meal at 45°C and pH of 8.5 includes:
1)将脱脂豆粉与水混合,调节pH值至8.5,45℃搅拌,得提取液;1) Mix defatted soybean powder with water, adjust the pH value to 8.5, and stir at 45°C to obtain an extract;
2)对提取液离心,向上清中加入固体NaSHO3至0.98g/L,调节pH至6.4,过夜;2) Centrifuge the extract, add solid NaSHO 3 to 0.98 g/L to the supernatant, adjust the pH to 6.4, and leave it overnight;
3)将上清液调pH至5.5,搅拌0.5h,离心,收集的上清液用纯水稀释2倍,调节pH至5.0,离心20min,取上清。3) The supernatant was adjusted to pH 5.5, stirred for 0.5 h, centrifuged, the collected supernatant was diluted 2 times with pure water, adjusted to pH 5.0, centrifuged for 20 min, and the supernatant was taken.
作为上述技术方案优选的技术方案,以CaCl2沉淀剂对β-伴大豆球蛋白进行沉淀的过程为:将CaCl2以1:5(m/v)的比例分散在水中,4℃透析48h,将透析完全的蛋白溶液冷冻干燥,得β-伴大豆球蛋白。As the preferred technical solution of the above technical solution, the process of precipitating β-conglycinin with CaCl 2 precipitant is as follows: CaCl 2 is dispersed in water at a ratio of 1:5 (m/v), dialyzed at 4°C for 48h, The dialyzed protein solution was freeze-dried to obtain β-conglycinin.
作为上述技术方案优选的技术方案,脱脂豆粉与水的比例为1:5(m/v)。As a preferred technical solution of the above technical solution, the ratio of defatted soybean meal to water is 1:5 (m/v).
作为上述技术方案优选的技术方案,所述搅拌为搅拌2h。As a preferred technical solution of the above technical solution, the stirring is stirring for 2h.
作为上述技术方案优选的技术方案,所述离心为9000g、4℃、离心30min。As a preferred technical solution of the above technical solution, the centrifugation is 9000g, 4°C, and centrifugation for 30 minutes.
上述制备方法制备得到的不同亚基组成β-伴大豆球蛋白在制备降血脂药物中的应用。The application of the different subunit composition β-conglycinin prepared by the above preparation method in the preparation of hypolipidemic drugs.
经由上述的技术方案可知,与现有技术相比,本发明公开提供了一种不同亚基组成β-伴大豆球蛋白的制备方法,通过控制提取时的温度、pH值,并加入沉淀剂,提高了提取效率。It can be known from the above technical solutions that, compared with the prior art, the present invention provides a preparation method of β-conglycinin with different subunit compositions. By controlling the temperature and pH value during extraction, and adding a precipitating agent, Improved extraction efficiency.
附图说明Description of drawings
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据提供的附图获得其他的附图。In order to explain the embodiments of the present invention or the technical solutions in the prior art more clearly, the following briefly introduces the accompanying drawings that need to be used in the description of the embodiments or the prior art. Obviously, the accompanying drawings in the following description are only It is an embodiment of the present invention. For those of ordinary skill in the art, other drawings can also be obtained according to the provided drawings without creative work.
图1附图为不同亚基组成蛋白对3T3-L1细胞油红O染色的影响。Figure 1 shows the effects of different subunit constituent proteins on the oil red O staining of 3T3-L1 cells.
图2附图为不同亚基组成蛋白处理对3T3-L1前脂肪细胞中脂质积累的影响,与模型组相比,***p<0.001;Figure 2 shows the effect of different subunit constituent protein treatments on lipid accumulation in 3T3-L1 preadipocytes, compared with the model group, ***p<0.001;
图3附图为不同亚基组成蛋白处理对3T3-L1前脂肪细胞中葡萄糖摄取(A)和甘油释放(B)的影响;与模型组相比,**p<0.01,***p<0.001;Figure 3 shows the effects of different subunit composition protein treatments on glucose uptake (A) and glycerol release (B) in 3T3-L1 preadipocytes; compared with the model group, **p<0.01, ***p< 0.001;
图4附图为亚基组成对SPI吸水吸油性的影响。Figure 4 shows the effect of subunit composition on the water and oil absorption of SPI.
具体实施方式Detailed ways
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, but not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.
实施例1β-伴大豆球蛋白的制备Example 1 Preparation of β-conglycinin
选择专用不同亚基组成大豆,且颗粒饱满、大小均匀、色泽一致,将野生型大豆和不同亚基组成大豆经去皮处理后粉碎研磨过80目筛;在室温条件下,称取一定量大豆粉末以1:5(m/v)的比例与正己烷混合制备脱脂豆粉,将上述脱脂豆粉与水以1:15(m/v)的比例进行混合,用2M NaOH调节pH至8.5,45℃充分搅拌2h后,9000g、4℃、离心30min,取其上清液加入固体NaSHO3至0.98g/L,调节pH至6.4,过夜;将上清液调pH至5.5,搅拌0.5h,9000g、4℃、离心30min,收集的上清液用纯水稀释2倍,调节pH至5.0,6500g、4℃、离心20min,将沉淀以1:5(m/v)的比例分散在水中,4℃透析48h(期间至少换水4次),将透析完全的蛋白溶液冷冻干燥后储存备用。Select special soybeans composed of different subunits, and the particles are plump, uniform in size, and consistent in color. The wild-type soybeans and soybeans composed of different subunits are peeled and then crushed and ground through an 80-mesh sieve; at room temperature, weigh a certain amount of soybeans The powder was mixed with n-hexane at a ratio of 1:5 (m/v) to prepare defatted soybean powder. The above defatted soybean powder was mixed with water at a ratio of 1:15 (m/v), and the pH was adjusted to 8.5 with 2M NaOH. After fully stirring at 45°C for 2h, centrifuge at 9000g, 4°C for 30min, take the supernatant, add solid NaSHO 3 to 0.98g/L, adjust the pH to 6.4, overnight; adjust the pH of the supernatant to 5.5, stir for 0.5h, 9000g, 4°C, centrifugation for 30min, the collected supernatant was diluted 2 times with pure water, adjusted to pH 5.0, 6500g, 4°C, centrifugation for 20min, the precipitate was dispersed in water at a ratio of 1:5 (m/v), Dialyzed at 4°C for 48 h (water was changed at least 4 times during the period), and the fully dialyzed protein solution was freeze-dried and stored for later use.
实施例2温度、pH值和沉淀剂的加入与否对提取率的影响Example 2 Influence of temperature, pH value and addition of precipitant on extraction rate
选择专用不同亚基组成大豆,且颗粒饱满、大小均匀、色泽一致,将野生型大豆和不同亚基组成大豆经去皮处理后粉碎研磨过80目筛;在室温条件下,称取一定量大豆粉末以1:5(m/v)的比例与正己烷混合制备脱脂豆粉,将上述脱脂豆粉与水以1:15(m/v)的比例进行混合,用2MNaOH调节pH至8.5,温度分别取25℃、35℃、45℃、55℃、65℃进行单因素实验,9000g、4℃、离心30min,取其上清液加入固体NaSHO3至0.98g/L,调节pH至6.4,过夜;将上清液调pH至5.5,搅拌0.5h,9000g、4℃、离心30min,收集的上清液用纯水稀释2倍,调节pH至5.0,6500g、4℃、离心20min,将沉淀以1:5(m/v)的比例分散在水中,4℃透析48h(期间至少换水4次),将透析完全的蛋白溶液冷冻干燥后储存备用。Select special soybeans composed of different subunits, and the particles are plump, uniform in size, and consistent in color. The wild-type soybeans and soybeans composed of different subunits are peeled and then crushed and ground through an 80-mesh sieve; at room temperature, weigh a certain amount of soybeans The powder is mixed with n-hexane in a ratio of 1:5 (m/v) to prepare defatted soybean powder, the above defatted soybean powder is mixed with water in a ratio of 1:15 (m/v), the pH is adjusted to 8.5 with 2M NaOH, and the temperature is adjusted to 8.5. Take 25°C, 35°C, 45°C, 55°C, and 65°C for single factor experiment, centrifuge at 9000g, 4°C for 30min, take the supernatant and add solid NaSHO 3 to 0.98g/L, adjust pH to 6.4, overnight ; Adjust the pH of the supernatant to 5.5, stir for 0.5h, centrifuge at 9000g, 4°C for 30min, dilute the collected supernatant by 2 times with pure water, adjust the pH to 5.0, centrifuge at 6500g, 4°C for 20min, and remove the precipitation with pure water. The ratio of 1:5 (m/v) was dispersed in water, dialyzed at 4°C for 48h (the water was changed at least 4 times during the period), and the completely dialyzed protein solution was freeze-dried and stored for later use.
pH值对提取效果的影响:将上述脱脂豆粉与水以1:15(m/v)的比例进行混合,用2MNaOH调节pH至7.5、8、8.5、9、9.5,充分搅拌2h后,提取温度为45℃进行单因素实验,9000g、4℃、离心30min,取其上清液加入固体NaSHO3至0.98g/L,调节pH至6.4,过夜;将上清液调pH至5.5,搅拌0.5h,9000g、4℃、离心30min,收集的上清液用纯水稀释2倍,调节pH至5.0,6500g、4℃、离心20min,将沉淀以1:5(m/v)的比例分散在水中,4℃透析48h(期间至少换水4次),将透析完全的蛋白溶液冷冻干燥后储存备用。The effect of pH value on the extraction effect: Mix the above defatted soybean powder with water at a ratio of 1:15 (m/v), adjust the pH to 7.5, 8, 8.5, 9, 9.5 with 2M NaOH, and after fully stirring for 2 hours, extract The temperature was 45°C for single factor experiment, 9000g, 4°C, centrifugation for 30min, the supernatant was added to solid NaSHO 3 to 0.98g/L, the pH was adjusted to 6.4, overnight; the supernatant was adjusted to pH 5.5, stirred for 0.5 h, 9000g, 4°C, centrifugation for 30min, the collected supernatant was diluted 2 times with pure water, adjusted to pH 5.0, 6500g, 4°C, centrifugation for 20min, and the precipitate was dispersed in the ratio of 1:5 (m/v). In water, dialyze at 4°C for 48h (the water was changed at least 4 times during the period), and freeze-dry the completely dialyzed protein solution and store it for later use.
沉淀剂CaCl2对提取效果的影响:将上述脱脂豆粉与水以1:15(m/v)的比例进行混合,用2M NaOH调节pH至8.5,充分搅拌2h后,提取温度为45℃进行单因素实验,9000g、4℃、离心30min,取其上清液加入固体NaSHO3至0.98g/L,再分别加0、5、10、20、30mmol/L沉淀剂CaCl2,调节pH至6.4,过夜;将上清液调pH至5.5,搅拌0.5h,9000g、4℃、离心30min,收集的上清液用纯水稀释2倍,调节pH至5.0,6500g、4℃、离心20min,将沉淀以1:5(m/v)的比例分散在水中,4℃透析48h(期间至少换水4次),将透析完全的蛋白溶液冷冻干燥后储存备用。The effect of the precipitant CaCl 2 on the extraction effect: The above defatted soybean powder was mixed with water at a ratio of 1:15 (m/v), and the pH was adjusted to 8.5 with 2M NaOH. After fully stirring for 2 hours, the extraction temperature was 45 °C. Single factor experiment, 9000g, 4℃, centrifugation for 30min, take the supernatant and add solid NaSHO 3 to 0.98g/L, then add 0, 5, 10, 20, 30mmol/L precipitant CaCl 2 respectively, adjust pH to 6.4 , overnight; the pH of the supernatant was adjusted to 5.5, stirred for 0.5 h, centrifuged at 9000g, 4°C for 30min, the collected supernatant was diluted 2 times with pure water, adjusted to pH 5.0, centrifuged at 6500g, 4°C for 20min, the The precipitate was dispersed in water at a ratio of 1:5 (m/v), dialyzed at 4°C for 48 h (water was changed at least 4 times during the period), and the fully dialyzed protein solution was freeze-dried and stored for later use.
根提取温度、pH值和CaCl2添加量对蛋白提取率的影响确定最佳提取条件Effects of root extraction temperature, pH value and CaCl 2 addition on protein extraction rate to determine optimal extraction conditions
结果见表1~表5;The results are shown in Table 1 to Table 5;
表1Table 1
由表1可知,高温有利于蛋白溶出,但过高会导致其变性。从表1可以看出,β-伴大豆球蛋白的蛋白质含量和提取率因温度的升高产生先升高后降低的现象,在45℃时条件最佳。It can be seen from Table 1 that high temperature is conducive to protein dissolution, but too high will lead to its denaturation. As can be seen from Table 1, the protein content and extraction rate of β-conglycinin increased first and then decreased with the increase of temperature, and the best conditions were at 45 °C.
表2 pH值对β-伴大豆球蛋白的影响Table 2 The effect of pH value on β-conglycinin
由表2可知,Thanh和Shibasaki方法制得溶液的pH值为8.0,但已知大豆球蛋白主要亚基的等电点为8.0-8.5,pH值从8.0调整到9.0时,β-伴大豆球蛋白的蛋白质含量和提取率先升高后降低。在pH8.5时,提取得到的蛋白质含量和提取率最高,It can be seen from Table 2 that the pH value of the solution prepared by the method of Thanh and Shibasaki is 8.0, but it is known that the isoelectric point of the main subunit of glycinin is 8.0-8.5. When the pH value is adjusted from 8.0 to 9.0, β-conglycinin The protein content and extraction of the protein first increased and then decreased. At pH 8.5, the protein content and extraction rate obtained by extraction were the highest,
表3沉淀剂量对β-伴大豆球蛋白的影响Table 3 The effect of precipitation dose on β-conglycinin
由表3可知,沉淀剂CaCl2增加导致β-伴大豆球蛋白的蛋白质含量下降,结果发现,添加10mmol/L CaCl2对β-伴大豆球蛋白的提取率有很大影响。It can be seen from Table 3 that the increase of the precipitant CaCl 2 leads to a decrease in the protein content of β-conglycinin, and it is found that the addition of 10 mmol/L CaCl 2 has a great influence on the extraction rate of β-conglycinin.
表4 Box-Behnken中心组合试验结果Table 4 Box-Behnken Center Combination Test Results
表5回归模型方程的方差分析Table 5 Analysis of variance of regression model equation
Tab.5Analysis of variance of the fitted regression modelTab.5Analysis of variance of the fitted regression model
使用Design-Expert 10.0.1分析试验数据,得到二次多项回归方程:Use Design-Expert 10.0.1 to analyze the test data and get the quadratic polynomial regression equation:
Y=39.806+0.04625*A+0.265*B-0.68125*C-0.175*AB+0.2075*AC+0.03*BC-0.81425*A2-1.22175*B2-0.38925*C2Y=39.806+0.04625*A+0.265*B-0.68125*C-0.175*AB+0.2075*AC+0.03*BC-0.81425*A2-1.22175*B2-0.38925*C2
式中Y为提取率,A为提取温度,B为pH值,C为CaCl2含量。where Y is the extraction rate, A is the extraction temperature, B is the pH value, and C is the CaCl content.
如表5所示,方差分析中F值用于检验每个变量对响应值影响的显著性的高低。F越大,相应变量的显著程度越高。当模型显著性检验p<0.05,表明该模型具有统计学意义。工艺条件对提取率影响大小顺序为:C>B>A,即CaCl2含量>pH值>提取温度。模型的决定系数R2=0.9909,说明模型具有高的显著性,此试验模型与真实数据拟合程度良好。As shown in Table 5, the F value in the analysis of variance is used to test the significance of the influence of each variable on the response value. The larger the F, the higher the significance of the corresponding variable. When the model significance test p<0.05, it indicates that the model is statistically significant. The order of the effect of process conditions on the extraction rate is: C>B>A, that is, CaCl 2 content>pH value>extraction temperature. The coefficient of determination of the model, R 2 =0.9909, indicates that the model has high significance, and the experimental model fits well with the real data.
为进一步准确确定最佳提取方法,以最大化提取率为优化目标,根据Design-Expert 10.0.1软件运行结果,最优工艺为:提取温度为46℃、pH值为8.5、CaCl2含量为0.9mmol/L,得到的最大提取率和质量分数分别为40.088%和89.85%。In order to further accurately determine the optimal extraction method and maximize the extraction rate as the optimization objective, according to the running results of the Design-Expert 10.0.1 software, the optimal process is as follows: the extraction temperature is 46 °C, the pH value is 8.5, and the CaCl 2 content is 0.9 mmol/L, the maximum extraction rate and mass fraction obtained were 40.088% and 89.85%, respectively.
在此条件下重复三次试验,最终测得1号提取率为41.010%,β-伴大豆球蛋白的质量分数为90.67%,与预测值偏差不大(p>0.05),这表明该模型是可靠的。此时2号的提取率为和质量分数分别为37.131%和89.51%,3号的提取率为38.499%和质量分数为90.03%,4号的提取率为和质量分数分别为39.054%和88.27%。Under these conditions, the experiment was repeated three times, and the extraction rate of No. 1 was finally measured to be 41.010%, and the mass fraction of β-conglycinin was 90.67%, which had little deviation from the predicted value (p>0.05), which indicated that the model was reliable. of. At this time, the extraction rate and quality fraction of No. 2 were 37.131% and 89.51%, the extraction rate and quality fraction of No. 3 were 38.499% and 90.03%, and the extraction rate and quality fraction of No. 4 were 39.054% and 88.27%, respectively. .
测得4组蛋白的亚基组成情况如下:The subunit compositions of the four histones were measured as follows:
表6四种β-伴大豆球蛋白亚基组成Table 6 Composition of four β-conglycinin subunits
实施例2降脂特性试验Example 2 Lipid-lowering property test
3T3-L1细胞的培养Culture of 3T3-L1 cells
3T3-L1前脂肪细胞在含10%FBS和抗生素(100U/mL青霉素和0.1μg/mL链霉素)的DMEM中,在37℃、5%CO2 20的湿润气氛中培养。前脂肪细胞完全融合后和暴露抑制2天,改为分化培养基I,包括0.5mM IBMX、1μM DEX和10μg/mL INS并培养2天(0-2天),将前脂肪细胞与10DMEM中的%FBS加1μM INS(2-4天),然后,将细胞在补充有10%FBS的DMEM培养基中再培养4天(4-8天)。每2d更换一次培养基。3T3-L1 preadipocytes were cultured in DMEM containing 10% FBS and antibiotics (100 U/mL penicillin and 0.1 μg/mL streptomycin) at 37°C in a humidified atmosphere of 5
脂质积累的测定Determination of lipid accumulation
油红O染色(ORO)用于确定成熟脂肪细胞中过量的脂质积累。完全分化的3T3-L1前脂肪细胞用PBS洗涤两次,并用4%多聚甲醛在25℃下固定30min。固定细胞用PBS缓冲液连续洗涤3次,然后用60%异丙醇洗涤5min。细胞用ORO溶液染色20min,然后用蒸馏水洗涤。最后,采用倒置荧光显微镜(DMIL LED Fluo,德国)对细胞形态进行观察和拍照;Oil red O staining (ORO) was used to determine excess lipid accumulation in mature adipocytes. Fully differentiated 3T3-L1 preadipocytes were washed twice with PBS and fixed with 4% paraformaldehyde for 30 min at 25°C. Fixed cells were successively washed three times with PBS buffer and then washed with 60% isopropanol for 5 min. Cells were stained with ORO solution for 20 min and then washed with distilled water. Finally, the cell morphology was observed and photographed using an inverted fluorescence microscope (DMIL LED Fluo, Germany).
甘油三酯(TG)含量的测定Determination of triglyceride (TG) content
根据制造商的说明,通过应用甘油三酯比色测定试剂盒(Asan PharmaceuticalCompany,Ltd.,Yeongcheon,Kyungbuk,Korea)测量分化8天后3T3-L1前脂肪细胞中的甘油三酯(TG)含量。总之,用冷PBS洗涤细胞两次,用TritonX-100(50mmol/L Tris、0.15mol/LNaCl、10mmol/L乙二胺四乙酸、0.1%Tween-20)裂解分化的细胞,TG试剂盒和BCA试剂盒分别测定TG浓度和总蛋白浓度。Triglyceride (TG) content in 3T3-L1 preadipocytes after 8 days of differentiation was measured by applying a triglyceride colorimetric assay kit (Asan Pharmaceutical Company, Ltd., Yeongcheon, Kyungbuk, Korea) according to the manufacturer's instructions. In summary, cells were washed twice with cold PBS, differentiated cells were lysed with TritonX-100 (50 mmol/L Tris, 0.15 mol/L NaCl, 10 mmol/L EDTA, 0.1% Tween-20), TG kit and BCA The kits were used to measure TG concentration and total protein concentration, respectively.
葡萄糖摄取量和甘油释放量的测定Determination of glucose uptake and glycerol release
将完全分化的3T3-L1前脂肪细胞与DMEM一起培养,并与浓度为100μg/mL的β-伴大豆球蛋白孵育1天。根据制造商的说明,用葡萄糖测定试剂盒和甘油含量检测试剂盒测定葡萄糖摄取量和甘油释放量,甘油检测前,脂肪酶必须在70℃下灭活10min,并在5,000rpm室温下离心5min。Fully differentiated 3T3-L1 preadipocytes were cultured with DMEM and incubated with β-conglycinin at a concentration of 100 μg/mL for 1 day. Glucose uptake and glycerol release were determined with a glucose assay kit and a glycerol content assay kit according to the manufacturer's instructions. Before glycerol assay, lipase must be inactivated at 70 °C for 10 min and centrifuged at 5,000 rpm for 5 min at room temperature.
结果与分析results and analysis
ORO染色检查的细胞分化如图1所示。作为脂质积累逐渐发生,3T3-L1前脂肪细胞在诱导8天后分化为具有几个油滴的成熟脂肪细胞。与正常组相比,成熟脂肪细胞体积增大,呈圆形,充满大的脂滴(模型组)。加入蛋白后,油红O染色面积减少,颜色变浅,成熟脂肪细胞呈圆形少于模型组。初步结果表明,与1号相比,3号比其他组具有更多的抑制作用。Cell differentiation examined by ORO staining is shown in Figure 1. As lipid accumulation occurred gradually, 3T3-L1 preadipocytes differentiated into mature adipocytes with several oil droplets after 8 days of induction. Compared with the normal group, mature adipocytes were larger, round, and filled with large lipid droplets (model group). After the addition of protein, the oil red O staining area was reduced, the color became lighter, and the mature adipocytes were less round than the model group. Preliminary results showed that No. 3 had more inhibitory effects than No. 1 than the other groups.
与模型组相比,用蛋白处理的细胞显示出较低的细胞内脂质积累。这表明处理抑制了分化。此外,用不同亚基组成蛋白处理的3T3-L1前脂肪细胞中的TG含量分别显著(p<0.001)降低了33.25、24.8、44.36和33.57%。观察3号蛋白表现出低的TG积累,见图2;Cells treated with the protein showed lower intracellular lipid accumulation compared to the model group. This suggests that treatment inhibits differentiation. Furthermore, TG content in 3T3-L1 preadipocytes treated with different subunit constituent proteins was significantly (p<0.001) decreased by 33.25, 24.8, 44.36 and 33.57%, respectively. It was observed that protein No. 3 showed low TG accumulation, as shown in Figure 2;
同时检测了培养基中的葡萄糖浓度以评估3T3-L1前脂肪细胞的葡萄糖摄取,不同亚基组成蛋白组的葡萄糖消耗显著增加(p<0.01)。与模型组相比,葡萄糖摄取量分别上升至0.86、0.81、0.98和0.82倍。特别是,3号显著增加了3T3-L1前脂肪细胞的葡萄糖摄取(p<0.001)。体内血糖的稳定性主要是通过胰岛素调节脂肪组织和骨骼肌组织中的葡萄糖转运来实现的。胰岛素敏感性描述了胰岛素抵抗的程度。胰岛素敏感性受损的标志是胰岛素刺激的葡萄糖摄取减少和胰岛素对脂肪组织脂肪分解能力的抑制降低。这表明3号蛋白可以促进3T3-L1前脂肪细胞对葡萄糖的摄取和利用,并对受损的胰岛素敏感性和胰岛素抵抗有特定的改善作用。The glucose concentration in the medium was also measured to evaluate the glucose uptake of 3T3-L1 preadipocytes, and the glucose consumption of the different subunit composition protein groups was significantly increased (p<0.01). Compared with the model group, the glucose intake increased to 0.86, 0.81, 0.98 and 0.82 times, respectively. In particular, No. 3 significantly increased glucose uptake in 3T3-L1 preadipocytes (p<0.001). The stability of blood glucose in vivo is mainly achieved by insulin regulation of glucose transport in adipose tissue and skeletal muscle tissue. Insulin sensitivity describes the degree of insulin resistance. The hallmarks of impaired insulin sensitivity are decreased insulin-stimulated glucose uptake and decreased insulin inhibition of adipose tissue lipolytic capacity. This suggests that
TG的主要功能是储存和供应能量。甘油三酯脂肪酶的水解释放甘油和游离脂肪酸供身体组织使用。因此,甘油释放代表脂肪细胞中的脂肪分解。我们对从分化的3T3-L1前脂肪细胞释放到培养基中的甘油释放量进行了体外测定。结果显示,与正常组相比,在分化的3T3-L1前脂肪细胞的细胞外培养基中,不同亚基组成蛋白处理后甘油释放量显著增加。与1号相比,3号的甘油含量明显低于其他组(p<0.05),表明3号蛋白可以显著抑制脂肪细胞中甘油的释放。抑制脂肪细胞分化可以防止脂肪组织的扩张,可用于肥胖管理;见图3;The main function of TG is to store and supply energy. Hydrolysis of triglyceride lipase releases glycerol and free fatty acids for use by body tissues. Thus, glycerol release represents lipolysis in adipocytes. We performed an in vitro assay of the amount of glycerol released into the culture medium from differentiated 3T3-L1 preadipocytes. The results showed that, compared with the normal group, in the extracellular medium of differentiated 3T3-L1 preadipocytes, the amount of glycerol released after treatment with different subunit constituent proteins was significantly increased. Compared with No. 1, the glycerol content of No. 3 was significantly lower than other groups (p<0.05), indicating that No. 3 protein could significantly inhibit the release of glycerol in adipocytes. Inhibition of adipocyte differentiation prevents adipose tissue expansion and can be used for obesity management; see Figure 3;
根据4种蛋白亚基组成含量与甘油三酯含量(Y)建立线性回归方程,Y=0.161α'-0.855α+0.193β+114.989,我们发现α亚基与甘油三酯含量呈显著负相关。与上述指标结果保持一致,α亚基含量最少时显示出更好的降脂效果。A linear regression equation was established according to the composition content of four protein subunits and triglyceride content (Y), Y=0.161α'-0.855α+0.193β+114.989, we found that α subunit was significantly negatively correlated with triglyceride content. Consistent with the above index results, a better lipid-lowering effect was shown when the α subunit content was the least.
实施例3不同亚基组成蛋白的吸水性与吸油性Example 3 Water and oil absorption of different subunit constituent proteins
吸水性与吸油性的测定Determination of water and oil absorption
0.3g蛋白样品加入3mL水(油)置于5mL离心管中,震荡混匀后静置30min,以10000g离心30min,吸附表面的非结合水(油)后记录重量,吸水性(Water absorption capacity,WAC)用每克蛋白吸附的水的质量来计算,吸油性(Oil absorption capacity,OAC)的计算方式是每克蛋白吸附的油的质量。公式如下:0.3g of protein sample was added to 3mL of water (oil) and placed in a 5mL centrifuge tube, shaken and mixed, and then allowed to stand for 30min, centrifuged at 10,000g for 30min, and the weight was recorded after adsorbing the unbound water (oil) on the surface. Water absorption capacity, WAC) was calculated by the mass of water adsorbed per gram of protein, and Oil absorption capacity (OAC) was calculated by the mass of oil adsorbed per gram of protein. The formula is as follows:
式中:m1为蛋白样品的质量(g);In the formula: m 1 is the mass (g) of the protein sample;
m2为离心前管加蛋白样品的质量(g);m 2 is the mass (g) of the protein sample added to the tube before centrifugation;
m3为离心后管加样品的质量(g);m 3 is the mass (g) of the sample added to the tube after centrifugation;
m4为蛋白样品的质量(g);m 4 is the mass (g) of the protein sample;
m5为离心前管加蛋白样品的质量(g);m 5 is the mass (g) of the protein sample added to the tube before centrifugation;
m6为离心后管加样品的质量(g)。m 6 is the mass (g) of the sample added to the tube after centrifugation.
蛋白质的理化特性主要是水和性质、表面性质和蛋白质之间的相互作用。吸水性是蛋白质和水之间的相互作用,是衡量蛋白产品吸附能力的大小;吸油性是蛋白质的非极性区域和脂质的非极性脂肪族链之间的疏水相互作用,表明蛋白质吸附油脂能力的大小。不同亚基组成SPI的吸水性和吸油性比较如图4所示,3号(52.72%)及4号(56.64%)的吸水性比1号(78.35%)低,而2号的吸水性比1号高,这一结果表明,亚基组成对蛋白吸水能力有一定影响。3号的吸油性(15%)比1号(14.65%)略高,而其他组蛋白并无明显差异(p>0.05)。本说明书中各个实施例采用递进的方式描述,每个实施例重点说明的都是与其他实施例的不同之处,各个实施例之间相同相似部分互相参见即可。The physicochemical properties of proteins are mainly the interactions between water and properties, surface properties and proteins. Water absorption is the interaction between protein and water, which is a measure of the adsorption capacity of protein products; oil absorption is the hydrophobic interaction between the non-polar regions of proteins and the non-polar aliphatic chains of lipids, indicating protein adsorption The size of the grease capacity. The comparison of water and oil absorption of SPI with different subunit compositions is shown in Figure 4. The water absorption of No. 3 (52.72%) and No. 4 (56.64%) is lower than that of No. 1 (78.35%), while the water absorption of No. 2 is lower than that of No. 2 (56.64%). No. 1 high, this result shows that the subunit composition has a certain influence on the water absorption capacity of the protein. The oil absorption of No. 3 (15%) was slightly higher than that of No. 1 (14.65%), while other histones had no significant difference (p>0.05). The various embodiments in this specification are described in a progressive manner, and each embodiment focuses on the differences from other embodiments, and the same and similar parts between the various embodiments can be referred to each other.
对所公开的实施例的上述说明,使本领域专业技术人员能够实现或使用本发明。对这些实施例的多种修改对本领域的专业技术人员来说将是显而易见的,本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下,在其它实施例中实现。因此,本发明将不会被限制于本文所示的这些实施例,而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。The above description of the disclosed embodiments enables any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein, but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210507021.7A CN114874301A (en) | 2022-05-10 | 2022-05-10 | Preparation method and application of β-conglycinin composed of different subunits |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210507021.7A CN114874301A (en) | 2022-05-10 | 2022-05-10 | Preparation method and application of β-conglycinin composed of different subunits |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114874301A true CN114874301A (en) | 2022-08-09 |
Family
ID=82676479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210507021.7A Pending CN114874301A (en) | 2022-05-10 | 2022-05-10 | Preparation method and application of β-conglycinin composed of different subunits |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114874301A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1622760A (en) * | 2002-01-29 | 2005-06-01 | 因德纳有限公司 | A process for the extraction, purification and enzymatic modification of soy 7S globulin alpha' subunit for use as hypocholesterolemizing agent |
-
2022
- 2022-05-10 CN CN202210507021.7A patent/CN114874301A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1622760A (en) * | 2002-01-29 | 2005-06-01 | 因德纳有限公司 | A process for the extraction, purification and enzymatic modification of soy 7S globulin alpha' subunit for use as hypocholesterolemizing agent |
Non-Patent Citations (5)
Title |
---|
KYOKO SAIO等: "FOOD USE OF SOYBEAN 7s AND 11s PROTEINS Extraction and Functional Properties of Their Fractions", 《JOURNAL OF FOOD SCIENCE》, vol. 38, no. 7, pages 1139 - 1144 * |
刁桂珠;潘俊波;姜自芹;葛玉君;郑天慧;曾蕊;吴帅;宋波;拓云;刘珊珊;: "大豆7S、11S球蛋白亚基缺失突变体豆腐加工特性的鉴定", 东北农业大学学报, no. 05 * |
彭易柱;: "大豆球蛋白及β-伴大豆球蛋白的研究进展", 当代畜牧, no. 36 * |
王昱婷;王笑宇;许晶;: "大豆球蛋白和β-伴大豆球蛋白的富集分离研究", 中国粮油学报, no. 08 * |
王昱婷等: "大豆球蛋白和β-伴大豆球蛋白的富集分离研究", 《中国粮油学报》, vol. 31, no. 8, pages 1 - 2 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Das et al. | Antidiabetic potential of soy protein/peptide: A therapeutic insight | |
JP2004505625A (en) | Conversion and modification of natural drugs by co-fermentation culture of intestinal symbiotic organisms | |
JP2001504443A (en) | Use of artichoke (Cynara) extract | |
Hou et al. | Beneficial effects of mung bean seed coat on the prevention of high-fat diet-induced obesity and the modulation of gut microbiota in mice | |
CN105853467B (en) | Application of lactobacillus reuteri GMNL-263 in preparation of hypolipidemic composition | |
CN104522664B (en) | Health food with capability of improving immunity and preparation method of health food | |
CN101664180B (en) | Health-care nutritional complexing agent with health effect and preparation method thereof | |
Du et al. | Fu brick tea protects against high-fat diet-induced obesity phenotypes via promoting adipose browning and thermogenesis in association with gut microbiota | |
Li et al. | In vitro dynamic digestion and anti-fatigue effects of wheat embryo albumin | |
Li et al. | Quinoa Peptides Alleviate Obesity in Mice Induced by a High‐Fat Diet via Regulating of the PPAR‐α/γ Signaling Pathway and Gut Microbiota | |
CN111449247A (en) | Tumor patient sea cucumber peptide nutritional supplement and processing method thereof | |
CN115252692A (en) | Application of traditional Chinese medicine composition in preparation of medicine for treating diseases related to hyperuricemia | |
CN114874301A (en) | Preparation method and application of β-conglycinin composed of different subunits | |
TWI619507B (en) | Active ingredient for treatment or prevention of allergic diseases | |
CN102934769B (en) | Bee pollen mixture buccal tablet for alleviating hangovers | |
Yao et al. | Anti-obesity effect of an isoflavone fatty acid ester on obese mice induced by high fat diet and its potential mechanism | |
Xu et al. | Attenuating effect of casein glycomacropeptide on proliferation, differentiation, and lipid accumulation of in vitro Sprague-Dawley rat preadipocytes | |
CN117503848A (en) | Anti-inflammatory lipid-reducing ferment and preparation method thereof | |
K Ramadan et al. | Role of pumpkin seed oil on some cardiovascular and renal aspects in adult male albino rats | |
CN116114876A (en) | Hypoglycemic composition containing sugarcane polyphenol and chlamydomonas reinhardtii and preparation method thereof | |
Zhu et al. | Alleviation of high-fat-diet induced obesity and cholesterol accumulation in mice by extracts from male zooid of antheraea pernyi | |
WO2017031981A1 (en) | Composition for body slimming and skin care and preparation method thereof | |
Yang et al. | Fermented yak-kong using Bifidobacterium animalis derived from Korean infant intestine effectively relieves muscle atrophy in an aging mouse model | |
Zhang et al. | Immunopotentiating effect of a ‘Yang’‐promoting formula of traditional Chinese medicine on aged female BALB/c mice | |
CN1895504A (en) | Chinese medicine for treating osteoporosis and its preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220809 |
|
RJ01 | Rejection of invention patent application after publication |